(3R,4S)-4-甲基-3-(甲基-7H-吡咯并[2,3-D]嘧啶-4-氨基)-BETA-氧代-1-哌啶丙腈 基本信息
中文名称 | (3R,4S)-4-甲基-3-(甲基-7H-吡咯并[2,3-D]嘧啶-4-氨基)-BETA-氧代-1-哌啶丙腈 |
---|---|
中文同义词 | (3R,4S)-4-甲基-3-(甲基-7H-吡咯并[2,3-D]嘧啶-4-氨基)-BETA-氧代-1-哌啶丙腈;混旋托法替尼API杂质 100MG;混旋托法替尼API杂质;托法替尼杂质ABCDEFGH;托法替布杂质TFB-A;1托法替尼杂质A;3托法替尼杂质A;托法替尼杂质340 |
英文名称 | 3-((3R,4S)-4-Methyl-3-(Methyl(7H-pyrrolo[2,3-d]pyriMidin-4-yl)aMino)piperidin-1-yl)-3-oxopropanenitrile |
英文同义词 | 3-((3R,4S)-4-Methyl-3-(Methyl(7H-pyrrolo[2,3-d]pyriMidin-4-yl)aMino)piperidin-1-yl)-3-oxopropanenitrile;1-Piperidinepropanenitrile, 4-Methyl-3-(Methyl-7H-pyrrolo[2,3-d]pyriMidin-4-ylaMino)-β-oxo-, (3R,4S)-;RS-tofacitinib citirate;Tofacitinib IMpurity E;Tofacitinib Impurity A(3R,4S);(3R,4S)-4-Methyl-3-(methyl-7H-pyrrolo[2,3-d]pyrimidin-4-ylamino)-β-oxo-1-piperidinepropanenitrile;(3R,4S)-4-Methyl-3-(Methyl-7H-pyrrolo[2,3-d]pyriMidin-4-ylaMino)-beta-oxo-1-piperidinepropanenitrile;Tofacitinib impurity 10/(3R,4S)-Tofacitinib/3-((3R,4S)-4-methyl-3-(methyl(7H-pyrrolo[2,3-d]pyrimidin-4-yl)amino) piperidin-1-yl)-3-oxopropanenitrile |
CAS号 | 1092578-46-5 |
分子式 | C16H20N6O |
分子量 | 312.3696 |
EINECS号 | |
相关类别 | 化学试剂、精细化学品、医药中间体、材料中间体;对照品-杂质对照品;托法替尼杂质对照品;杂质对照品 |
Mol文件 | 1092578-46-5.mol |
结构式 |
(3R,4S)-4-甲基-3-(甲基-7H-吡咯并[2,3-D]嘧啶-4-氨基)-BETA-氧代-1-哌啶丙腈 性质
熔点 | >108°C (dec.) |
---|---|
密度 | 1.296 |
储存条件 | Refrigerator |
溶解度 | 可溶于氯仿(轻微)、DMSO(轻微)、甲醇(轻微、加热) |
形态 | 固体 |
酸度系数(pKa) | 6.04±0.60(Predicted) |
颜色 | 淡黄色至黄色凝胶至 |